Fresenius Medical Care AG & Co. KGaA (FMEN) Stock Forecast & Price Target
FMEN Analyst Ratings
Moderate Sell
1Buy4Hold5Sell
Based on 10 analysts giving stock ratings to Fresenius Medical Care AG & Co. KGaA in the past 3 months
FMEN Stock 12 Month Forecast
Average Price Target
MXN 758.71â–¼(-7.70% Downside)Based on 10 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is MXN 758.71 with a high forecast of MXN 925.45 and a low forecast of MXN 621.80. The average price target represents a -7.70% change from the last price of MXN 822.02.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 925.45
AverageMXN 758.71
LowMXN 621.80
Highest Price TargetHighestMXN 925.45Average Price TargetMXN 758.71Lowest Price TargetLowestMXN 621.80
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Richard Felton | Goldman Sachs | MXN 787.61→MXN 777.25 | hold | -5.45%Downside | Reiterated | 11/09/26 | ||
| Hassan Al-Wakeel | Barclays | MXN 922.34→MXN 725.43 | sell | -11.75%Downside | Downgraded | 11/09/26 | ||
| Falko Friedrichs | Deutsche Bank | MXN 829.07 | hold | 0.86%Upside | Reiterated | 11/04/26 | ||
| Anna Ractliffe | Bank of America Securities | MXN 663.25 | sell | -19.31%Downside | Reiterated | 11/04/26 | ||
| James Vane | Jefferies | MXN 621.80 | sell | -24.36%Downside | Reiterated | 11/03/26 | ||
| Susannah Ludwig | Bernstein | MXN 925.45 | hold | 12.58%Upside | Reiterated | 11/03/26 | ||
| David Adlington | J.P. Morgan | MXN 669.47 | sell | -18.56%Downside | Reiterated | 11/03/26 | ||
| Graham Doyle | UBS | MXN 746.16 | sell | -9.23%Downside | Reiterated | 11/03/26 | ||
 Unknown AnalystNot Ranked | DZ BANK AG | ― | buy | ― | Reiterated | 10/21/26 | ||
| Harry Gillis | Berenberg Bank | MXN 1,243.60→MXN 870.52 | hold | 5.90%Upside | Downgraded | 09/29/26 | ||
| Aisyah Noor | Morgan Stanley | MXN 663.25→MXN 642.53 | sell | -21.84%Downside | Reiterated | 08/05/26 | ||
| Veronika Dubajova | Citi | MXN 829.07→MXN 849.79 | hold | 3.38%Upside | Reiterated | 07/17/26 | ||
| Oliver Reinberg | Kepler Capital | MXN 891.25 | hold | 8.42%Upside | Reiterated | 05/05/26 | ||
| Harald Hof | mwb research | MXN 953.43→MXN 974.15 | buy | 18.51%Upside | Upgraded | 01/12/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Richard FeltonGoldman Sachs | HoldReiteratedMXN 787.61→MXN 777.25 | 11/09/26 | -5.45%Downside | ||
| Hassan Al-WakeelBarclays | SellDowngradedMXN 922.34→MXN 725.43 | 11/09/26 | -11.75%Downside | ||
| Falko FriedrichsDeutsche Bank | HoldReiteratedMXN 829.07 | 11/04/26 | 0.86%Upside | ||
| Anna RactliffeBank of America Securities | SellReiteratedMXN 663.25 | 11/04/26 | -19.31%Downside | ||
| James VaneJefferies | SellReiteratedMXN 621.80 | 11/03/26 | -24.36%Downside | ||
| Susannah LudwigBernstein | HoldReiteratedMXN 925.45 | 11/03/26 | 12.58%Upside | ||
| David AdlingtonJ.P. Morgan | SellReiteratedMXN 669.47 | 11/03/26 | -18.56%Downside | ||
| Graham DoyleUBS | SellReiteratedMXN 746.16 | 11/03/26 | -9.23%Downside | ||
| Unknown AnalystDZ BANK AGNot Ranked | BuyReiterated | 10/21/26 | ― | ||
| Harry GillisBerenberg Bank | HoldDowngradedMXN 1,243.60→MXN 870.52 | 09/29/26 | 5.90%Upside | ||
| Aisyah NoorMorgan Stanley | SellReiteratedMXN 663.25→MXN 642.53 | 08/05/26 | -21.84%Downside | ||
| Veronika DubajovaCiti | HoldReiteratedMXN 829.07→MXN 849.79 | 07/17/26 | 3.38%Upside | ||
| Oliver ReinbergKepler Capital | HoldReiteratedMXN 891.25 | 05/05/26 | 8.42%Upside | ||
| Harald Hofmwb research | BuyUpgradedMXN 953.43→MXN 974.15 | 01/12/26 | 18.51%Upside |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Fresenius Medical Care AG & Co. KGaA
3 Months
Success Rate24/53 ratings generated profit
45%
Average Return
-3.21%
Copying James Vane's trades and holding each position for 3 Months would result in 45.28% of your transactions generating a profit, with an average return of -3.21% per trade.
1 Year
Success Rate27/53 ratings generated profit
51%
Average Return
-3.37%
Copying James Vane's trades and holding each position for 1 Year would result in 50.94% of your transactions generating a profit, with an average return of -3.37% per trade.
2 Years
Success Rate20/53 ratings generated profit
38%
Average Return
-7.86%
Copying James Vane's trades and holding each position for 2 Years would result in 37.74% of your transactions generating a profit, with an average return of -7.86% per trade.
FMEN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 1 |
| Hold | 8 | 8 | 9 | 9 | 8 |
| Sell | 17 | 16 | 12 | 15 | 14 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 26 | 25 | 22 | 26 | 23 |
In the current month, FMEN has received 1 Buy Ratings, 8 Hold Ratings, and 14 Sell Ratings. FMEN average Analyst price target in the past 3 months is 758.71.
FMEN Financial Forecast
HighMXN 27.00
ConsensusMXN 21.12
LowMXN 15.29
FMEN Earnings Forecast
Next quarter’s earnings estimate for FMEN is MXN 21.12 with a range of MXN 15.29 to MXN 27.00. The previous quarter’s EPS was MXN 23.05. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighMXN 116B
ConsensusMXN 106B
LowMXN 103B
FMEN Sales Forecast
Next quarter’s sales forecast for FMEN is MXN 106.34B with a range of MXN 103.18B to MXN 116.32B. The previous quarter’s sales results were MXN 102.53B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
FMEN Stock Forecast FAQ
What is MX:FMEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is Mex$758.71.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
Fresenius Medical Care AG & Co. KGaA has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 4 hold ratings and 5 sell ratings.
What is Fresenius Medical Care AG & Co. KGaA’s share price target?
The average share price target for Fresenius Medical Care AG & Co. KGaA is Mex$758.71. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$925.45, and the lowest forecast is Mex$621.80. The average share price target represents a 7.70% decrease from the current price of Mex$822.02.
What do analysts say about Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
To buy shares of MX:FMEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
